• Editorial Team

Webinar - SMID-Cap Biotech & Pharma and ESG

Updated: Jun 3, 2019

Why is now the time for small- and mid-cap biotech & pharma executives, directors, IROs and legal teams to learn more about the “Environmental, Social and Governance” (ESG) landscape, where to start and how best to communicate to investors?

Given the rapid rise of interest in the topic by institutional investors and other company stakeholders, senior management teams and corporate directors increasingly need to take a proactive approach with their companies’ ESG policies and messaging. This is the case even if your shareholders and analysts have never asked you questions about ESG factors or your ESG ratings.

Join ESG industry leaders for a conversation that’s specific to biotech & pharma:

• Introduction to ESG

• Investor engagement on ESG

• ESG and SMID-cap biotech & pharma

• Tips for effective ESG planning

• Industry examples





Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

RECEIVE OUR RESEARCH UPDATES

We'll send you our must-read research updates and latest articles. 

SALES OFFICE
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ
United Kingdom
UK CLIENT SUPPORT
& RESEARCH CENTRE

Pembroke House

Llantarnam Park Way

Cwmbran, NP44 3AU

United Kingdom

US OFFICE
333 Albert Ave.,
Suite 430
East Lansing
MI 48823
United States
CONTACT INFORMATION
support@leadersarena.global
Europe: +44 20 3884 0310
US & Canada: +1 517 325 2310
  • LinkedIn
  • Twitter

Copyright Leaders Arena Limited © 2020 • View our Privacy Policy

Leaders Arena Limited is a registered company in England and Wales, Company Number 10242863, headquartered at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
Leaders Arena Inc., incorporated in Delaware (US), is a wholly owned subsidiary of Leaders Arena Limited.